Microplate Dx


Microplate Dx is an innovative diagnostics company dedicated to combating antimicrobial resistance worldwide. They develop rapid antibiotic susceptibility testing solutions, including their patented RapidPlate technology, which aims to provide quick, accurate results to improve treatment decisions and patient outcomes. Their mission is to accelerate treatment decisions and improve patient quality of life through pioneering antimicrobial stewardship-enabling diagnostics, with a vision to be at the forefront of tackling the global antimicrobial resistance threat.

Industries

biotechnology
health-care
medical

Nr. of Employees

small (1-50)

Microplate Dx

Glasgow, Glasgow City, United Kingdom, Europe


Products

Rapid diagnostic platform for urinary tract infection susceptibility

A miniaturized diagnostic platform that combines biosensor electrodes with hydrogel-deposited antibiotics and algorithmic analysis to generate rapid antibiotic susceptibility results for urinary tract infections.


Services

Clinical feasibility studies for diagnostic devices

Design and execution of pre-clinical and clinical feasibility evaluations in collaboration with healthcare providers to assess diagnostic performance and clinical utility.

R&D collaborations and partnership development

Collaborative development partnerships with academic and clinical organisations to advance assay and device development toward deployment.

Expertise Areas

  • Antimicrobial susceptibility testing (AST)
  • Diagnostics development and validation
  • Biosensor and assay development
  • Data science and diagnostic analytics
  • Show More (4)

Key Technologies

  • Biosensor electrodes
  • Hydrogel-based reagent deposition
  • Rapid antibiotic susceptibility testing (AST)
  • Algorithmic data processing for diagnostics
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.